Jinyu Bio-Technology Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 1.20%

Jinyu Bio-Technology Co Ltd (600201) has an Asset Resilience Ratio of 1.20% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Jinyu Bio-Technology Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥78.48 Million
≈ $11.48 Million USD Cash + Short-term Investments

Total Assets

CN¥6.54 Billion
≈ $956.56 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Jinyu Bio-Technology Co Ltd's Asset Resilience Ratio has changed over time. See Jinyu Bio-Technology Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Jinyu Bio-Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Jinyu Bio-Technology Co Ltd worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥78.48 Million 1.2%
Total Liquid Assets CN¥78.48 Million 1.20%

Asset Resilience Insights

  • Limited Liquidity: Jinyu Bio-Technology Co Ltd maintains only 1.20% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Jinyu Bio-Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jinyu Bio-Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
argenx NV ADR
NASDAQ:ARGX
Biotechnology 10.93%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 2.03%
Tubize-Fin
BR:TUB
Biotechnology 0.05%
Hebei Changshan Biochem Pharma
SHE:300255
Biotechnology -0.03%
Neuren Pharmaceuticals Ltd
AU:NEU
Biotechnology 90.43%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076
Biotechnology 2.30%
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871
Biotechnology 6.52%
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880
Biotechnology 5.52%

Annual Asset Resilience Ratio for Jinyu Bio-Technology Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Jinyu Bio-Technology Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.82% CN¥120.11 Million
≈ $17.58 Million
CN¥6.61 Billion
≈ $967.48 Million
+1.27pp
2024-12-31 0.54% CN¥36.83 Million
≈ $5.39 Million
CN¥6.76 Billion
≈ $989.88 Million
+0.00pp
2023-12-31 0.54% CN¥37.27 Million
≈ $5.45 Million
CN¥6.87 Billion
≈ $1.01 Billion
-0.19pp
2022-12-31 0.73% CN¥46.94 Million
≈ $6.87 Million
CN¥6.39 Billion
≈ $934.96 Million
-2.05pp
2021-12-31 2.78% CN¥183.85 Million
≈ $26.90 Million
CN¥6.60 Billion
≈ $966.36 Million
-7.40pp
2020-12-31 10.19% CN¥639.48 Million
≈ $93.58 Million
CN¥6.28 Billion
≈ $918.71 Million
-1.85pp
2019-12-31 12.04% CN¥672.48 Million
≈ $98.40 Million
CN¥5.59 Billion
≈ $817.39 Million
-0.63pp
2018-12-31 12.67% CN¥800.00 Million
≈ $117.07 Million
CN¥6.31 Billion
≈ $923.82 Million
-1.40pp
2017-12-31 14.08% CN¥800.00 Million
≈ $117.07 Million
CN¥5.68 Billion
≈ $831.69 Million
+8.05pp
2016-12-31 6.03% CN¥262.00 Million
≈ $38.34 Million
CN¥4.35 Billion
≈ $636.21 Million
--
pp = percentage points

About Jinyu Bio-Technology Co Ltd

SHG:600201 China Biotechnology
Market Cap
$1.91 Billion
CN¥13.09 Billion CNY
Market Cap Rank
#6452 Global
#1384 in China
Share Price
CN¥11.77
Change (1 day)
-1.09%
52-Week Range
CN¥7.81 - CN¥18.78
All Time High
CN¥30.02
About

Jinyu Bio-technology Co., Ltd. manufacturing and sales of veterinary biological drugs in China. The company operates through three segments, such as veterinary biological products, veterinary chemical drugs, and traditional Chinese veterinary medicines. The company offers various pig vaccines, including combined porcine circovirus type 2 and mycoplasma pneumoniae, classical swine fever, combined … Read more